Moomoo AI 已提取核心信息
Austin Che has filed an amendment with the Securities and Exchange Commission, disclosing a 5.6% ownership stake in Ginkgo Bioworks Holdings, Inc. This Schedule 13G/A filing, dated December 31, 2023, indicates that Che has sole voting and dispositive power over 95,898,483 shares of the company's Class A Common Stock. The filing details the composition of the shares, including those held directly by Che, as well as those held through various trusts. The shares of Class B Common Stock, which Che holds, can be converted to Class A shares on a one-to-one basis. The filing, completed on February 14, 2024, asserts that the acquisition of these shares is not intended to change or influence the control of Ginkgo Bioworks and is not in connection with any transaction with such purpose.
Austin Che has filed an amendment with the Securities and Exchange Commission, disclosing a 5.6% ownership stake in Ginkgo Bioworks Holdings, Inc. This Schedule 13G/A filing, dated December 31, 2023, indicates that Che has sole voting and dispositive power over 95,898,483 shares of the company's Class A Common Stock. The filing details the composition of the shares, including those held directly by Che, as well as those held through various trusts. The shares of Class B Common Stock, which Che holds, can be converted to Class A shares on a one-to-one basis. The filing, completed on February 14, 2024, asserts that the acquisition of these shares is not intended to change or influence the control of Ginkgo Bioworks and is not in connection with any transaction with such purpose.
奥斯汀·切已向美国证券交易委员会提交了一项修正案，披露了Ginkgo Bioworks Holdings, Inc.5.6％的所有权。该附表13G/A于2023年12月31日提交的文件显示，车对该公司A类普通股的95,898,483股拥有唯一的投票权和处置权。该文件详细说明了股票的构成，包括Che直接持有的股票以及通过各种信托持有的股份。Che持有的B类普通股可以一对一地转换为A类股票。该文件于2024年2月14日完成，声称收购这些股份无意改变或影响银杏生物工程的控制权，也与任何以此类目的的交易无关。
奥斯汀·切已向美国证券交易委员会提交了一项修正案，披露了Ginkgo Bioworks Holdings, Inc.5.6％的所有权。该附表13G/A于2023年12月31日提交的文件显示，车对该公司A类普通股的95,898,483股拥有唯一的投票权和处置权。该文件详细说明了股票的构成，包括Che直接持有的股票以及通过各种信托持有的股份。Che持有的B类普通股可以一对一地转换为A类股票。该文件于2024年2月14日完成，声称收购这些股份无意改变或影响银杏生物工程的控制权，也与任何以此类目的的交易无关。
有用
没用